Dhampur Bio Organics Ltd

Q2 FY26Agricultural Food & other Products

Dhampur Bio Organics Q2 FY26: Revenue ₹793.22 Cr, PAT ₹15.53 Cr

Q2 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹113

Market cap₹772 Cr

P/E30.2

Updated24 Sept 2026

Read3 min read

Based on Dhampur Bio Organics Ltd's Q2 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q2FY26 revenue from operations: ₹793.22 Crores (up 25.20% YoY from ₹633.58 Crores) - Sugar sales: 96,220 tons (down 2.95% YoY from 99,147 tons); revenue ₹419.81 Crores (up 4.23% YoY) - Biofuel & Spiri EBITDA for Q2FY26: ₹5.87 Crores, up from a loss of ₹7.43 Crores in Q2FY25, representing a positive YoY change.

From Dhampur Bio Organics Ltd's Q2 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

Q2FY26 revenue from operations: ₹793.22 Crores (up 25.20% YoY from ₹633.58 Crores)
Sugar sales: 96,220 tons (down 2.95% YoY from 99,147 tons); revenue ₹419.81 Crores (up 4.23% YoY)
Biofuel & Spirits sales: ethanol sales 16.863 Mn BL (up 63% YoY from 10.321 Mn BL); revenue ₹95.54 Crores (up 46.85% YoY)
Country Liquor sales: 1,161,538 cases (up 52.79% YoY from 760,200 cases); revenue ₹29.24 Crores (net of excise, up 54.22% YoY)
Volume increases mainly in Biofuel & Spirits and Country Liquor; slight volume decrease in Sugar

2 more points management made on revenue & sales performance

Profitability & Margins

EBITDA for Q2FY26: ₹5.87 Crores, up from a loss of ₹7.43 Crores in Q2FY25, representing a positive YoY change.
EBITDA Margin for Q2FY26: 0.74%, improved from (1.17%) in Q2FY25.
Profit After Tax (PAT) for Q2FY26: Loss of ₹15.53 Crores, improved from a loss of ₹22.46 Crores in Q2FY25.

2 more points management made on profitability & margins

See what Dhampur Bio Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The investor presentation does not explicitly mention any specific capex, capacity expansion, or new plant/project with amounts, status, or timelines. It provides current operational capacities across three plants (Asmoli, Mansurpur, Meerganj) detailing sugarcane crushing, sugar refinery, pharma-grade sugar, bio-fuels & spirits, potable liquor, power generation, and CO2 production capacities. There is no stated information on future capital expenditure, expansion plans, or new projects in the provided content.

Top-ranked in Agricultural Food & other Products

Ranked on what management guided this quarter

5x potential

1Regaal Resources₹927 Cr

Rev 1Mar 2

2Prospect Consum.₹21 Cr

Rev 1Mar 3

3₹250 Cr

Rev 2Mar 1

4₹218 Cr

Rev 2Mar 1

5₹2.7K Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The presentation notes long-term and short-term credit ratings assigned at A- and A2+ (Outlook-Stable) by Care Ratings (Page 25).
The company repaid long-term loans of ₹17.6 crores during Q2FY26 (Page 25).
Long term loans as on September 30, 2025, were ₹286 crores, and net working capital was ₹309 crores (Page 25).
Long term debt to equity ratio slightly improved from 0.30 times as of March 31, 2025, to 0.29 times as of September 30, 2025 (Page 25).

2 more points management made on fundraising & capital structure

See what Dhampur Bio Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation for Dhampur Bio Organics Limited does not report any information related to: - Order book - Order inflow - Pending orders No data or metrics regarding orders or order backlog are mentioned within the provided slides or content. The presentation focuses primarily on financial results, operational highlights, segment performance, and shareholder information without reference to order status.

Dhampur Bio Organics Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹486 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Dhampur Bio Organics Ltd's management said in earlier quarters

Others in Agricultural Food & other Products this season

Magadh Sugar & Energy Ltd (Q2 FY26)
Revenue: Rs 244 Cr (Q2FY26) vs Rs 265 Cr (Q2FY25) – decline of Rs 21 Cr . Key concall takeaways from Magadh Sugar & Energy Ltd's Q2 FY26 earnings call — and…
Dwarikesh Sugar Industries Ltd (Q2 FY26)
Revenue from operations dropped to ₹0 million from ₹191.8 million; EBITDA margin fell from -32.8% to 0%. Key concall takeaways from Dwarikesh Sugar Industries…
Dhampur Sugar Mills Ltd (Q2 FY26)
712.1 Crore vs Rs. Key concall takeaways from Dhampur Sugar Mills Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
Avadh Sugar & Energy Ltd (Q2 FY26)
Q2 FY26: Rs 668 Cr vs Rs 632 Cr in Q2 FY25 (up Rs 36 Cr) . Key concall takeaways from Avadh Sugar & Energy Ltd's Q2 FY26 earnings call — and how it ranks…

Compare:vs Marico vs Tata Consumer Products Ltd vs Patanjali Foods

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Dhampur Bio Organics Ltd Q2 FY26 results?

What is Dhampur Bio Organics Ltd share price analysis?

Dhampur Bio Organics Ltd currently shows a neutral. The stock trades at a P/E of 30.2 with a market cap of ₹772 Cr. Investors should review the full earnings analysis for detailed insights.

Is Dhampur Bio Organics Ltd planning capital expenditure?

The investor presentation does not explicitly mention any specific capex, capacity expansion, or new plant/project with amounts, status, or timelines.

Keep Dhampur Bio Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.